habener glp-1 Remembering Dr. Joel Who should win a Nobel

This has led to increased interest in GLP-1 drugs for weight management, even among non-diabetics

By competitively excluding other mucin-degrading bacteria, it concomitantly enhances host metabolic capacity, modulates immune responses, and mitigates pathogen-induced barrier impairment, thereby preserving mucus layer and intestinal epithelial homeostasis [52]

Users have found that alternate routes of administration that skip the stomach entirely are effective at mitigating digestive issues

10.1111/bph.15508 [DOI] [PMC free article] [PubMed] [Google Scholar] Holst, J

These are the biological actors whose normal functions set the stage for understanding both what goes wrong in diabetes and how our medications are trying to fix it

Weight Loss: GLP-1 agonists will slow down the digestion of food and give a feeling of satiety